Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab while Maintaining Immunotherapy.
Saved in:
| Title: | Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab while Maintaining Immunotherapy. |
|---|---|
| Authors: | Florea CM; Department of Medical Oncology, Sion Hospital, Sion, Switzerland., Parmentier L; Department of Dermatology, Sion Hospital, Sion, Switzerland., Abdou M; Department of Dermatology, Sion Hospital, Sion, Switzerland.; Department of Pathology, Central Institute - Sion Hospital, Sion, Switzerland., Berthod G; Department of Medical Oncology, Sion Hospital, Sion, Switzerland. |
| Source: | Case reports in oncology [Case Rep Oncol] 2025 Jul 25; Vol. 18 (1), pp. 1171-1177. Date of Electronic Publication: 2025 Jul 25 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 101517601 Publication Model: eCollection Cited Medium: Print ISSN: 1662-6575 (Print) Linking ISSN: 16626575 NLM ISO Abbreviation: Case Rep Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
